AI in pharma is rapidly growing as companies adopt intelligent technologies to streamline R&D, enhance trial success rates, automate production, and deliver personalized treatments. With the market projected to reach $15.2 billion by 2030, AI is becoming a strategic priority for competitive advantage. To know in detail, visit our latest blog post about AI in Pharma & Biotech: Future Use Cases & Trends 2026.